JUN and acute myeloid leukemia: Interestingly, as illustrated in Fig. 8, consistent with the above facts, our meta- and gene set enrichment analysis in AML chemo-resistance samples showed significant inhibition of JNK signaling due to simultaneous down-regulation of c-Jun and up-regulation of AKT3 expression.